150 related articles for article (PubMed ID: 33363940)
21. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
Hida Y; Kubo Y; Murao K; Arase S
Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
[TBL] [Abstract][Full Text] [Related]
22. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light.
Takata M; Rehman I; Rees JL
Int J Cancer; 1997 May; 71(3):370-2. PubMed ID: 9139870
[TBL] [Abstract][Full Text] [Related]
23. Primary Extramammary Paget's Disease Combined with Bowen's Disease in Vulva.
Kim SA; Kwon JI; Jung HR; Lee KS; Cho JW
Ann Dermatol; 2011 Oct; 23(Suppl 2):S222-5. PubMed ID: 22148056
[TBL] [Abstract][Full Text] [Related]
24. Two major pathways of penile carcinogenesis: HPV-induced penile cancers overexpress p16ink4a, HPV-negative cancers associated with dermatoses express p53, but lack p16ink4a overexpression.
Mannweiler S; Sygulla S; Winter E; Regauer S
J Am Acad Dermatol; 2013 Jul; 69(1):73-81. PubMed ID: 23474228
[TBL] [Abstract][Full Text] [Related]
25. p16INK4a expression in actinic keratosis and Bowen's disease.
Salama ME; Mahmood MN; Qureshi HS; Ma C; Zarbo RJ; Ormsby AH
Br J Dermatol; 2003 Nov; 149(5):1006-12. PubMed ID: 14632806
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical localization of keratins and involucrin in solar keratosis and Bowen's disease.
Ichikawa E; Watanabe S; Otsuka F
Am J Dermatopathol; 1995 Apr; 17(2):151-7. PubMed ID: 8600780
[TBL] [Abstract][Full Text] [Related]
27. Ki-67 and p53 expression in cutaneous Bowen's disease: an immunohistochemical study of fixed-embedded tissue sections.
Szekeres G; De Giacomoni P
Acta Derm Venereol; 1994 Mar; 74(2):95-7. PubMed ID: 7911636
[TBL] [Abstract][Full Text] [Related]
28. p53 Deficiency leads to compensatory up-regulation of p16INK4a.
Leong WF; Chau JF; Li B
Mol Cancer Res; 2009 Mar; 7(3):354-60. PubMed ID: 19240179
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus Detection Rates in Bowen's Disease: Correlation with Pelvic and Digital Region Involvement and Specific p53 Immunostaining Patterns.
Kim YC; Woo B; Kim HN; Kim KE; Jeon J; Kim C; Baek YS
Clin Exp Dermatol; 2024 Feb; ():. PubMed ID: 38365318
[TBL] [Abstract][Full Text] [Related]
30. The inhibitory effect of UVB irradiation on the expression of p53 and Ki-67 proteins in arsenic-induced Bowen's disease.
Chai CY; Yu HS; Yen HT; Tsai KB; Chen GS; Yu CL
J Cutan Pathol; 1997 Jan; 24(1):8-13. PubMed ID: 9027627
[TBL] [Abstract][Full Text] [Related]
31. p53 gene mutations in Bowen's disease in Koreans: clustering in exon 5 and multiple mutations.
Lee HJ; Kim JS; Ha SJ; Roh KY; Seo EJ; Park WS; Lee JY; Park KS; Kim JW
Cancer Lett; 2000 Sep; 158(1):27-33. PubMed ID: 10940505
[TBL] [Abstract][Full Text] [Related]
32. Potential role of the OVOL1-OVOL2 axis and c-Myc in the progression of cutaneous squamous cell carcinoma.
Ito T; Tsuji G; Ohno F; Nakahara T; Uchi H; Furue M
Mod Pathol; 2017 Jul; 30(7):919-927. PubMed ID: 28339425
[TBL] [Abstract][Full Text] [Related]
33. Pigmented Bowen's disease and review of 420 Bowen's disease lesions.
Ragi G; Turner MS; Klein LE; Stoll HL
J Dermatol Surg Oncol; 1988 Jul; 14(7):765-9. PubMed ID: 3292613
[TBL] [Abstract][Full Text] [Related]
34. Mutant p53 protein is expressed in Bowen's disease.
Sim CS; Slater SD; McKee PH
Am J Dermatopathol; 1992 Jun; 14(3):195-9. PubMed ID: 1510215
[TBL] [Abstract][Full Text] [Related]
35. Bowen's disease with invasive adnexal carcinoma: the pluripotential nature of Bowen's disease cells.
Kamiya H; Kitajima Y; Ban M
J Dermatol; 2006 Dec; 33(12):858-64. PubMed ID: 17169090
[TBL] [Abstract][Full Text] [Related]
36. hYSK1 promotes cancer cell proliferation and migration through negative regulation of p16
Lee MH; Dong Z; Surh YJ; Choi BY
Oncotarget; 2017 Oct; 8(51):89072-89085. PubMed ID: 29179500
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
38. Bowen's disease with features resembling myrmecia wart.
Hsu CK; Chen YC; Yang WL; Hsu KF; Chao SC; Lee JY
J Dermatol; 2015 Jan; 42(1):90-3. PubMed ID: 25387725
[TBL] [Abstract][Full Text] [Related]
39. A Case of Pigmented Bowen's Disease.
Lee JW; Hur J; Yeo KY; Yu HJ; Kim JS
Ann Dermatol; 2009 May; 21(2):197-9. PubMed ID: 20523786
[TBL] [Abstract][Full Text] [Related]
40. Lipopolysaccharides-Induced Inflammatory Response in White Blood Cells Is Associated with Alterations in Senescence Mediators: Modulation by Metformin.
Aljada A
Metab Syndr Relat Disord; 2015 Aug; 13(6):278-85. PubMed ID: 25871950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
